RUN insider files Form 144 to sell 1,005 RSU shares on 10/06/2025

Rhea-AI Filing Summary

Sunrun Inc. filing a Form 144 reports a proposed sale of 1,005 common shares, acquired on 10/06/2025 through an RSU lapse, with an aggregate market value of $19,435. The sale is planned through Charles Schwab & Co., Inc. on 10/06/2025 and the securities are listed on NASDAQ. The filer also disclosed a prior sale on 07/07/2025 of 988 shares for $10,670. The filing includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• RSU lapse acquisition indicates the shares were earned via compensation, not a private purchase
• Transaction size is small versus 230,732,572 outstanding shares
• Filer included required attestation stating no knowledge of undisclosed material adverse information

Negative

• Insider selling activity of 1,005 shares on 10/06/2025 plus prior 988 shares sold on 07/07/2025 totals 1,993 shares in three months
• Aggregate market value of the proposed sale is $19,435, providing limited market signaling but representing insider liquidity

Insights

Insider Transactions Analyst

TL;DR: Officer-level equity sale filed under Rule 144; trade size is modest relative to total shares outstanding.

The filing shows a proposed sale of 1,005 common shares acquired by RSU lapse on 10/06/2025 with an aggregate market value of $19,435, to be executed through Charles Schwab on 10/06/2025. The issuer's outstanding share count is listed as 230,732,572, making this sale a very small fraction of total equity.

Key dependencies include proper compliance with Rule 144 timing and any 10b5-1 plan terms; the filer affirms no undisclosed material adverse information. Monitor transaction settlement and any additional filings that would change the total insider selling volume in the near term (weeks).

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	1005	19435.00	230732572	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/06/2025	RSU Lapse - See Remarks	Sunrun Inc.			1005	10/06/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Maria Barak 600 CALIFORNIA STREET, SUITE 1800 SAN FRANCISCO CA 94108	Sunrun Inc.	07/07/2025	988	10670.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Sunrun (RUN) Form 144 filed on 10/06/2025 disclose?

The Form 144 discloses a proposed sale of 1,005 common shares acquired via RSU lapse on 10/06/2025 with aggregate market value $19,435, to be sold through Charles Schwab on 10/06/2025.

Who is handling the sale of the RUN shares?

The filing lists Charles Schwab & Co., Inc. as the broker for the proposed sale.

Has the filer sold other Sunrun shares recently?

Yes, the filer sold 988 shares on 07/07/2025 for $10,670 as disclosed in the filing.

How large is this insider sale relative to Sunrun's outstanding shares?

The filing lists 230,732,572 shares outstanding; the proposed 1,005-share sale is a very small fraction of that total.

Are there statements about undisclosed material information?

The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.